LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test

Sep 28, 2020

|

NEW YORK – Laboratory Corporation of America announced Monday an exclusive licensing agreement with Genfit to commercialize Genfit's NIS4 technology for patients with non-alcoholic steatohepatitis (NASH).

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

LabCorp, Genfit Partner to Commercialize Liver Disease Diagnostic Test

To read the full story....

Breaking News

BTIG Initiates Coverage of Progenity With Buy Rating

FDA Approves Avioq's Supplemental HIV Test

FDA Grants EUAs for Wren Labs, P23 Coronavirus Tests, Binx Health At-Home Sample Collection Kit

In Brief This Week: Oxford Immunotec, Eurofins, WHO, and More

Local Coverage Determinations Roundup: CareDx, Castle Bio, Decipher Biosciences

Genetron Health Licenses ImmuQuad Technology for Blood Cancer Testing

What's Popular?

COVID-19 Testing Plays Into Abbott's Long-Term Diagnostic Strategy

FDA Grants EUAs for Wren Labs, P23 Coronavirus Tests, Binx Health At-Home Sample Collection Kit

LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test

Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

Quest Diagnostics Q3 Revenues Rise 43 Percent

Sponsorships